CM directs thorough probe into supply of ‘substandard’ materials at GB Pant Hospital

New Delhi: Chief Minister Arvind Kejriwal on Tuesday directed Health Minister Satyendar Jain to initiate a “thorough probe” into the supply of “substandard” materials, including surgical gloves and syringes, at the Delhi government-run GB Pant Hospital, and take strong action against the supplier and guilty officials. In a written communication to Jain, the chief minister sought a report on the action taken in the matter by September 20.

“The health minister should order a thorough probe into this whole incident, fix responsibility and take strong action against the supplier and guilty officials. Remedial measures should be taken at the earliest. All possible steps should be undertaken to ensure that all consumable and non-consumable supplies in all government hospitals meet defined quality standards,” Kejriwal said.

“Receipt of torn gloves and broken syringes is result of lack of effective quality control and supervision on the part of the authorities concerned,” he said.

It has been “clearly established” that the disposable sterile surgical gloves were supplied in “torn” condition, Kejriwal said, citing a report of the medical director of GB Pant Hospital.

The report was “silent” on the quality of syringes, he added.

  • Related Posts

    Pain is passé in Blood Test, thanks to Metropolis’ Human Touch

    New Delhi: Blood drawing for test has really reached proverbial ant bite, thanks to introduction of innovative blood collection technology by Metropolis healthcare, India’s second largest pathology laboratory chain. First…

    60 Countries witnessed AMTZ, Seed of Global Hub of Medical Devices

    Vishakhapatnam: It could be the beginning of the end of dependence of India on imports of medical devices. Import lobby must have watched this gathering of 60 countries to witness…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt